Emmaus Life Sciences Inc (CE) (EMMA)
USOTC
News
Market Data
Register to chat with like-minded investors on our interactive forums.
The current EMMA market cap is 4.41M. The company's latest EPS is USD -0.0604 and P/E is -45.86.
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 22.75M | 23.17M | 20.61M | 18.39M | 29.6M |
| Operating Income | -4.93M | -2.35M | -8.86M | -8.5M | 1.83M |
| Net Income | -54.84M | 1.1M | -15.95M | -10.63M | -3.73M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 59.46M | 59.28M | 56.73M | 48.23M | 35.18M |
| Total Liabilities | 70.51M | 64.69M | 78.18M | 82.32M | 82.94M |
| Total Equity | -11.05M | -5.42M | -21.45M | -34.09M | -47.76M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -4.52M | -2.45M | -1.25M | -5.07M | -1.5M |
| Investing | -1.48M | 5.47M | -6.38M | -2.39M | -432k |
| Financing | 3.88M | -2.31M | 7.41M | 7.23M | 2.48M |
| Market Cap | 4.41M |
| Price to Earnings Ratio | -45.86 |
| Price to Sales Ratio | 5.79 |
| Price to Cash Ratio | 67.23 |
| Price to Book Ratio | -3.59 |
| Dividend Yield | - |
| Shares Outstanding | 61.85M |
| Average Volume (1 week) | 1.04k |
| Average Volume (1 Month) | 28.32k |
| 52 Week Change | -69.00% |
| 52 Week High | 0.28 |
| 52 Week Low | 0.0506 |
| Spread (Intraday) | 0 (0%) |
| Company Name | Emmaus Life Sciences Inc (CE) |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://www.emmausmedical.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
